Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

Nelson J. Chao, MD, Daniel T Grima, M.Sc., George Carrum, MD, Leona Holmberg, MD., PhD, Henry C. Fung, FRCP, MD, Stephen Brown, Ph.D., Mitchell E. Horwitz, MD, Lisa M Bernard, M.Sc., Junya Kanda, MD, Jane L. Liesveld, MD, Brian McClune, DO, Paul Shaughnessy, MD, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 4048.

https://doi.org/10.1182/blood.V118.21.4048.4048

Published: 2011

Journal Articles

Mismatches in Ethnicity Between Donor and Recipient Affects Overall Survival In Umbilical Cord Blood Transplantation,

Patali Shikhi Cheruku, Veronica H. Jude, MD, Renee M Madden, MD, Charles F. LeMaistre, MD, Ka Wah Chan, MD, MBBS, Paul Shaughnessy, MD, Carlos Bachier, MD

Blood (2011) 118 (21): 4159.

https://doi.org/10.1182/blood.V118.21.4159.4159

Published: 2011

Journal Articles

Seizures During Infusion of Autologous Peripheral Blood Stem Cells Are Related to High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product and Can Be Prevented by Dilution of Product with Autologous Plasma

Carlos Bachier, MD, Grant Potter, Joshua Potter, Charles F. LeMaistre, MD, Paul Shaughnessy, MD, Kawah Chan, MD, Veronica H. Jude, MD, Renee Madden

Blood (2011) 118 (21): 4386.

https://doi.org/10.1182/blood.V118.21.4386.4386

Published: 2011

Journal Articles

Upfront Tandem Autologous Stem Cell Transplant Is Superior to Autologous or Allogeneic Stem Cell Transplant After Failure of a 1st Autologous Transplant,

Adrian Wong, MD, Charles F. LeMaistre, MD, Paul Shaughnessy, MD, Carlos Bachier, MD

Blood (2011) 118 (21): 4094.

https://doi.org/10.1182/blood.V118.21.4094.4094

Published: 2011

Journal Articles

Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

Nelson J. Chao, MD, Lisa M Bernard, M.Sc., George Carrum, MD, Henry C. Fung, FRCP, MD, Daniel T Grima, M.Sc., Leona Holmberg, MD., PhD, Stephen Brown, Ph.D., Mitchell E. Horwitz, MD, Junya Kanda, MD, Jane L. Liesveld, MD, Brian McClune, DO, Paul Shaughnessy, MD, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 1925.

https://doi.org/10.1182/blood.V118.21.1925.1925

Published: 2011

Journal Articles

High Correlation of Pre-Apheresis Peripheral Blood CD34+ Cell Counts with Final Apheresis Product CD34+ Cell Count by Using a More Accurate Determination of Patient Blood Volume

Brandon Parker, James Hastings, Jill Folkert, RN, Gayla Nagy, RN, Carlos Bachier, MD, Charles F. LeMaistre, MD, Paul Shaughnessy, MD

Blood (2011) 118 (21): 2996.

https://doi.org/10.1182/blood.V118.21.2996.2996

Published: 2011

Journal Articles

Oral Loading of Tacrolimus and Sub-Therapeutic Levels on the Day of Transplant Do Not Predict the Incidence of Acute Graft Versus Disease or Survival After Allogeneic Stem Cell Transplant

Jill MacPherson, FNP-BC, AOCNP, Carlos Bachier, MD, Charles F. LeMaistre, MD, Hannah Sowell, RN, Luis Garcia, RN, Alessandra Curel-Sanchez, RN, Wilma Cain, RN, Ursula Caga, RN, Jeremy Means, RN, Paul Shaughnessy, MD

Blood (2011) 118 (21): 4543.

https://doi.org/10.1182/blood.V118.21.4543.4543

Published: 2011

Journal Articles

Collection of Autologous Peripheral Blood Stem Cells Using the COBE Spectra Is Associated with Higher CD34+ Yields and Requires Less Collection Time Than the Fresenius AS104 Cell Separator.

Grant W Potter, Charles F. LeMaistre, MD, Paul Shaughnessy, MD, Miguel Islas, MD, Juan Huerta, Carlos Bachier, MD

Blood (2009) 114 (22): 2158.

https://doi.org/10.1182/blood.V114.22.2158.2158

Published: 2009

Journal Articles

Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.

Paul Shaughnessy, MD, Miguel Islas-Ohlmayer, MD, Julie Murphy, Maureen Hougham, RN, Jill MacPherson, FNP, Kurt Winkler, PharmD, Matthew Silva, PharmD, Michael Steinberg, PharmD, Jeffrey Matous, MD, Sheryl Selvey, PharmD, Michael Maris, MD, Peter A. McSweeney, MD

Blood (2009) 114 (22): 2277.

https://doi.org/10.1182/blood.V114.22.2277.2277

Published: 2009

Journal Articles

Plerixafor (Mozobil ® )Plus G-CSF Is Effective in Mobilizing Hematopoietic Stem Cells in Patients with Concurrent Thrombocytopenia Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Ivana N Micallef, MD, Eric Jacobsen, Paul Shaughnessy, MD, Sachin Marulkar, MBBS, MPH, Purvi Mody, PhD, Frits van Rhee, MD, PhD

Blood (2009) 114 (22): 3229.

https://doi.org/10.1182/blood.V114.22.3229.3229

Published: 2009

Journal Articles

Cost Analysis of Mobilization and Autologous Transplantation in Patients Who Received AMD 3100 after Failing Standard Mobilization.

Elina Delgado, Charles F. LeMaistre, MD, Carlos Bachier, Brad Smith, PhD, Guillermo López-González, Maureen Hougham, Shawn Kaleel, Paul Shaughnessy, MD

Blood (2008) 112 (11): 2151.

https://doi.org/10.1182/blood.V112.11.2151.2151

Published: 2008

Journal Articles

Clinical and Cost Outcomes of Double Umbilical Cord Blood Versus Bone Marrow and Peripheral Blood Unrelated Hematopoietic Stem Cell Transplants.

Guillermo López-González, Charles F. LeMaistre, MD, Carlos Bachier, MD, Brad Smith, PhD, Ka Wah Chan, MBBS, Michael Grimley, MD, Wilma Cain, Elina Delgado, Shawn Kaleel, Paul Shaughnessy, MD

Blood (2008) 112 (11): 967.

https://doi.org/10.1182/blood.V112.11.967.967

Published: 2008

Journal Articles

Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor Is an Alternative to Donor Lymphocyte Infusion for Relapse after Allogeneic Stem Cell Transplantation and Is Associated with Increase Immune Effector Cells and Polarization to Type 2 Dendritic Cells.

Carlos R. Bachier, MD, Paul Shaughnessy, MD, Brad Smith2, PhD, Richard Salinas, Charles F. LeMaistre, MD

Blood (2007) 110 (11): 1647.

https://doi.org/10.1182/blood.V110.11.1647.1647

Published: 2007

Journal Articles

Pre-Transplant Biomarkers Predict GVHD and Treatment-Related Mortality in Patients Treated with Extracorporeal Photopheresis Prior to Allogeneic Bone Marrow Transplantation.

Peter J. O’Brien, PhD, Brian Bolwell, MD, Sunil Abhyankar, MD, Paul Shaughnessy, MD, Koen van Besien, MD, Paul Williamson, MD, Kim A. Campbell, PhD

Blood (2006) 108 (11): 5182.

https://doi.org/10.1182/blood.V108.11.5182.5182

Published: 2006

Journal Articles

Valganciclovir for the Early Prophylaxis of Cytomegalovirus (CMV) Infection after Allogeneic Stem Cell Transplantation.

Carlos Bachier, MD, Paul Shaughnessy, MD, Donna Wall, MD, Michael Grimley, MD, George Carrum, MD, Cesar Freytes, MD, Natalie Callander, MD, Tracey Walsh, PharmD, C. Fred LeMaistre, MD

Blood (2004) 104 (11): 5074.

https://doi.org/10.1182/blood.V104.11.5074.5074

Published: 2004

Journal Articles

Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study.

Tracey L. Walsh, PharmD, Carlos Bachier, MD, Paul Shaughnessy, MD, Cesar O. Freytes, MD, Natalie Callander, MD, C. Fred LeMaistre, MD, Michael Grimley, MD, Patrick Bradshaw, MS

Blood (2004) 104 (11): 5096.

https://doi.org/10.1182/blood.V104.11.5096.5096

Published: 2004

NARROW

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

Mismatches in Ethnicity Between Donor and Recipient Affects Overall Survival In Umbilical Cord Blood Transplantation,

Seizures During Infusion of Autologous Peripheral Blood Stem Cells Are Related to High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product and Can Be Prevented by Dilution of Product with Autologous Plasma

Upfront Tandem Autologous Stem Cell Transplant Is Superior to Autologous or Allogeneic Stem Cell Transplant After Failure of a 1st Autologous Transplant,

Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

High Correlation of Pre-Apheresis Peripheral Blood CD34+ Cell Counts with Final Apheresis Product CD34+ Cell Count by Using a More Accurate Determination of Patient Blood Volume

Oral Loading of Tacrolimus and Sub-Therapeutic Levels on the Day of Transplant Do Not Predict the Incidence of Acute Graft Versus Disease or Survival After Allogeneic Stem Cell Transplant

Collection of Autologous Peripheral Blood Stem Cells Using the COBE Spectra Is Associated with Higher CD34+ Yields and Requires Less Collection Time Than the Fresenius AS104 Cell Separator.

Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.

Plerixafor (Mozobil ® )Plus G-CSF Is Effective in Mobilizing Hematopoietic Stem Cells in Patients with Concurrent Thrombocytopenia Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Cost Analysis of Mobilization and Autologous Transplantation in Patients Who Received AMD 3100 after Failing Standard Mobilization.

Clinical and Cost Outcomes of Double Umbilical Cord Blood Versus Bone Marrow and Peripheral Blood Unrelated Hematopoietic Stem Cell Transplants.

Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor Is an Alternative to Donor Lymphocyte Infusion for Relapse after Allogeneic Stem Cell Transplantation and Is Associated with Increase Immune Effector Cells and Polarization to Type 2 Dendritic Cells.

Pre-Transplant Biomarkers Predict GVHD and Treatment-Related Mortality in Patients Treated with Extracorporeal Photopheresis Prior to Allogeneic Bone Marrow Transplantation.

Valganciclovir for the Early Prophylaxis of Cytomegalovirus (CMV) Infection after Allogeneic Stem Cell Transplantation.

Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only